Earnings from Edwards Lifesciences Corporation [EW] are scheduled on April 20, 2021, after the market closes. It is expected that the company will report weak earnings for the quarter ending Mar 2021.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .
EW Stock Earnings Outlook For The Current Quarter
The consensus estimates for the quarter suggest that the company would earn $0.47 per share on revenue of $1.16B. Taking a look at the future, the company is projected to report revenue of $1.25B at an earnings per share of $0.52 for the Jun 2021 quarter. The estimates represent year-over-year improvements of 11.70% in revenue and 16.50% in earnings per share for the company.
EW Stock Earnings Forecast For The Current Year
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
For the full financial year, Edwards Lifesciences Corporation [NYSE:EW] is forecasted to generate revenue of $5.08B. The figure is about $690.0 million above what the company actually reported for the fiscal year 2020. In terms of EPS, it is estimated to be $2.13 in 2021, which is $0.27 higher than the figure in FY20. Based on current estimates, earnings are expected to grow 14.50% this year, 16.40% next year, and 12.99% annually over the next five years. With regard to sales, forecasts suggest an incline of 15.80% in current fiscal year and 11.70% over following year.
EW Stock Price Performance
At a recent check today, Edwards Lifesciences Corporation [NYSE:EW] finished up 1.87% at $90.21. The stock’s day high price was $89.03, and its lowest was $87.81. Its price rose 3.19% in the last five days. Since the beginning of the year, Edwards Lifesciences Corporation’s shares are down nearly -2.93%. However, the share price is -2.03% below its one year high. The top price reached by the shares of the company was $91.73 on 01/04/21, while the 52-week low came on 03/19/21, when the shares were $78.44. In the past year, shares of the company have risen 16.32%. At 50 days, the moving average achieved is $84.04 while at 200 days, the moving average is $82.23. There were 0.91 million shares traded in the last session, down from 6.86 million in the previous session.
Edwards Lifesciences Corporation [NYSE:EW] Stock Valuation Metrics
With a prevailing 12-month PE ratio of 68.60, Edwards Lifesciences Corporation [EW] does not qualify as a good candidate for the list of underestimated low-priced stocks that should be purchased sooner rather than later. By this measure, the company’s stock is trading at a premium to the industry average of 35.82 times trailing earnings. Investors may find it helpful to look at historical price-sales ratios, and in the case of this stock, 12.46 PS value ratio is reported for the last one year of reported earnings. This is above the average return 5.79 for the industry, which means EW offers an unattractive investment opportunity than its competitors do.
EW Share Price Support And Resistance Levels
Based on the daily chart, the immediate backing lies around the 90.66 level, and the violation of this level will cause a further drop to 87.90 level. At the upper end, 90.34 remains a key resistance. As the stock increases, it may find resistance at 89.69. In the 14-day chart, the Relative Strength Index standing at 72.34 suggests a technical overbought stance while the MACD standing at 3.12 indicates price will increase in the next trading period. Stochastic %K at 95.65% suggests selling the stock while Percent R indicator at 3.70% suggests bullish price movement.
How much is the short interest in Edwards Lifesciences Corporation?
There have been a drop in short interest in the Edwards Lifesciences Corporation Financial stock, with short interest down by -0.31 million shares to 5.59 million shares on Feb 25, 2021. According to data provided by Yahoo Finance, the short interest on Mar 30, 2021 stood at 5.28 million shares. This 5.55% increase suggests some bearish sentiment was experienced by the stock. Shorted shares accounted for just 0.86% of the overall float in the stock, while the stock’s days to cover moved to 1.94.
How do analysts view Edwards Lifesciences Corporation?
In regard to the share price forecast for Edwards Lifesciences Corporation stock, the analysts, as surveyed by FactSet, forecast the price to reach $96.00 in the next twelve months, representing almost an 6.03% growth from its recent price of $90.21. Among Edwards Lifesciences Corporation stock projections, $111.00 is the highest analyst target for the stock, while $71.00 is the lowest. Despite this, 26 analysts who share their consensus rating for EW in 2021 agree that the stock is an Overweight.